Economic evaluations of pharmacogenetic and genomic screening programs: update of the literature.

Abstract excerpt

Pharmacogenetics and pharmacogenomics show great potential for developing individual treatment modalities to achieve optimal therapy effectiveness. Economic analyses are performed to determine whether pharmacogenetic screening strategies provide good value for money. The current review provides an update of published economic studies. Economic analyses of pharmacogenetic screening programs published between 2000 a...

Topics

Open a Topic to create a Post that cites this publication.

• Cost-Benefit Analysis
• Cytochrome P-450 Enzyme System
• Drug Therapy
• Genetic Testing
• Genotype
• Guidelines as Topic
• Pharmacogenetics
• Sensitivity and Specificity

Identifiers and source

Literature Corpus work

d6d4ce73-c332-5cbf-b886-6f608c17fe38

DOI

10.1002/ddr.20424